Immunogenicity, reactogenicity and safety of three-dose primary and booster vaccination with combined diphtheria-tetanus-whole-cell pertussis-hepatitis B-reduced antigen content Haemophilus influenzae type b vaccine in Filipino children

Human Vaccines

Volumn 6, Issue 8, 2010, Pages 664-672

  Gatchalian, Salvacion R ^a,b   Ramakrishnan, Gunasekaran ^b   Bock, Hans L ^b   Lefevre, Inge ^b   Jacquet, Jeanne M ^b  

^a RESEARCH INSTITUTE FOR TROPICAL MEDICINE   (Philippines)

^b GLAXOSMITHKLINE BIOLOGICALS   (Belgium)

Author keywords

Booster; Haemophilus influenzae type b; Hepatitis B vaccine; Immune memory; Philippines; Primary vaccination

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS HAEMOPHILUS INFLUENZAE TYPE B HEPATITIS B VACCINE; DIPHTHERIA PERTUSSIS TETANUS HEPATITIS B VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; THIOMERSAL; UNCLASSIFIED DRUG;

ANTIBODY RESPONSE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIPHTHERIA; DOUBLE BLIND PROCEDURE; DRUG SAFETY; ENZYME LINKED IMMUNOSORBENT ASSAY; HAEMOPHILUS INFECTION; HEPATITIS B; HUMAN; IMMUNOGENICITY; INFANT; INJECTION SITE INDURATION; INJECTION SITE REACTION; INJECTION SITE SWELLING; MAJOR CLINICAL STUDY; PERTUSSIS; PHILIPPINES; RANDOMIZED CONTROLLED TRIAL; REPEATED DRUG DOSE; TETANUS; TREATMENT OUTCOME; VACCINATION;

EID: 77956622560     PISSN: 15548600     EISSN: 15548619     Source Type: Journal    
DOI: 10.4161/hv.6.8.12155     Document Type: Article

References (37)

1. World Health Organization (WHO). Global Immunization Data January 2009. Available at http://www.who.int/immunization/newsroom/GID-english.pdf. Accessed on 2009.
2. World Health Organization (WHO). WHO Position Paper on Haemophilus influenzae. Wkly Epidemiol Rec 2006; 81:445-52.
3. Peltola H. Burden of meningitis and other severe bacterial infections of children in Africa: implications for prevention. Clin Infect Dis 2001; 32:64-75. (Pubitemid 32150952)
4. Andrade AL, Martelli CM. Globalisation of Hib vaccination-how far are we? Lancet 2005; 365:5-7.
5. Peltola H. Need for Haemophilus influenzae type b vaccination in Asia as evidenced by epidemiology of bacterial meningitis. Pediatr Infect Dis J 1988; 17:148-51.
6. UNICEF. Pneumonia: The forgotten killer. 2006; 34-7. Available at: www.unicef.org/publications/files/Pneumonia-The-Forgotten-Killer-of-Children. pdf. Accessed on 2008.
7. Lupisan SP, Herva E, Sombrero LT, Quiambao BP, Capeding MR, Abucejo EP, et al. Invasive bacterial infections of children in a rural province in the central Philippines. Am J Trop Med Hyg 2000; 62:341-6.
8. Song JH, Jung SI, Ko KS, Kim NY, Son JS, Chang HH, et al. High prevalence of antimicrobial resistance among clinical Streptococcus pneumoniae isolates in Asia (an ANSORP study). Antimicrob Agents Chemother 2004; 48:2101-7.
9. Limcangco MR, Salole EG, Armour CL. Epidemiology of Haemophilus influenzae type b meningitis in Manila, Philippines, 1994 to 1996. Pediatr Infect Dis J 2000; 19:7-11.
10. Lolekha S. A review of Hib epidemiology in Asia. Southeast Asian J Trop Med Public Health 2000; 31:650-7.
11. Prymula R, Plisek S. Clinical experience with DTPw-HBV and DTPw-HBV/Hib combination vaccines. Expert Opin Biol Ther 2008; 8:503-13. (Pubitemid 351570413)
12. Happe LE, Lunacsek OE, Marshall GS, Lewis T, Spencer S. Combination vaccine use and vaccination quality in a managed care population. Amer J Manag Care 2007; 13:506-12. (Pubitemid 47404427)
13. Happe LE, Lunacsek OE, Kruzikas DT, Marshall GS. Impact of a pentavalent combination vaccine on immunization timeliness in a state Medicaid population. Pediatr Infect Dis J 2009; 28:98-01.
14. Kalies H, Grote V, Verstraeten T, Hessel L, Schmitt HJ, von Kries R. The use of combination vaccines has improved timeliness of vaccination in children. Pediatr Infect Dis J 2006; 25:507-12. (Pubitemid 43863360)
15. Arístegui J, Usonis V, Coovadia H, Riedemann S, Win KM, Gatchalian S, et al. Facilitating the WHO expanded program of immunization: the clinical profile of a combined diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae type b vaccine. Int J Infect Dis 2003; 7:143-51. (Pubitemid 36753521)
16. Hla K, Thein S, Aye A, Han HH, Bock HL, David MP, et al. Reactogenicity and immunogenicity profiles of a novel pentavalent diphtheria-tetanus-whole cell pertussis-hepatitis B and Haemophilus influenzae type b vaccine: a randomized dose-ranging trial of the Hib tetanus conjugate content. Pediatr Infect Dis J 2006; 25:706-12. (Pubitemid 44162128)
17. Bravo L, Carlos J, Gatchalian S, Borja-Tabora C, Bibera G, Willems P, et al. The new DTPw-HBV-Hib combination vaccine can be used at the WHO schedule with a monovalent dose of hepatitis b vaccine at birth. Southeast Asian J Trop Med Public Health 1998; 29:772-8. (Pubitemid 128709190)
18. Lagos R, Valenzuela MT, Levine OS, Losonsky GA, Erazo A, Wasserman SS, et al. Economisation of vaccination against Haemophilus influenzae type b: a randomised trial of immunogenicity of fractional-dose and two-dose regimens. Lancet 1998; 351:1472-6. (Pubitemid 28227038)
19. Fernández J, Balter S, Feris J, Gómez E, Garib Z, Castellanos PL, et al. Randomized trial of the immunogenicity of fractional dose regimens of PRP-T Haemophilus influenzae type b conjugate vaccine. Am J Trop Med Hyg 2000; 62:485-90. (Pubitemid 32164756)
20. Huebner RE, Nicol M, Mothupi R, Käyhty H, Mbelle N, Khomo E, et al. Dose response of CRM197 and tetanus toxoid-conjugated Haemophilus influenzae type b vaccines. Vaccine 2004; 23:802-6. (Pubitemid 39473179)
21. Ortega-Barrìa E, Kanra G, Leroux G, Bravo L, Safary A, Lefevre I, et al. The immunogenicity and reactogenicity of DTPw-HBV/Hib 2.5 combination vaccine: results from four phase III multicenter trials across three continents. Vaccine 2007; 25:8432-40. (Pubitemid 350137598)
22. Tregnaghi M, López P, Rocha C, Rivera L, David MP, Rüttimann R, et al. A new DTPw-HB/Hib combination vaccine for primary and booster vaccination of infants in Latin America. Rev Panam Salud Publica/Pan Am J Public Health 2006; 19:179-88. (Pubitemid 44147374)
23. Gatchalian S, Reyes M, Bernal N, Lefevre I, David MP, Han HH, et al. A new DTPw-HBV/Hib vaccine is immunogenic and safe when administered according to the EPI (Expanded Programme for Immunization) schedule and following hepatitis B vaccination at birth. Human vaccines 2005; 1:198-203.
24. Gatchalian S, Reyes M, Bermal N, Chandrasekaran V, Han HH, Bock HL, et al. A new DTPw-HBV/Hib vaccine: Immune memory after primary vaccination and booster dosing in the second year of life. Human Vaccines 2008; 4:60-6. (Pubitemid 351785263)
25. Ramkisson A, Coovadia HM, Jugnundan P, Willems P, Clemens BR. A new combined DTP-HBV-Hib vaccine-strategy for incorporation of Hib vaccination into childhood immunisation programmes. S Afr Med J 2001; 91:864-9. (Pubitemid 33062318)
26. Santos JI, Martin A, De Leon T, Rivera L, Gaitán ME, Del Rio C, et al. DTPw-HB and Hib primary and booster vaccination: combined versus separate administration to Latin American children. Vaccine 2002; 20:1887-93. (Pubitemid 34242847)
27. Faingezicht I, Aguerro M, Cervantes Y, Fourneau M, Clemens S. Primary and booster vaccination with DTPw-HB/Hib pentavalent vaccine in Costa Rican children who had received a birth dose of hepatitis B vaccine. Rev Panam Salud Publica 2002; 12:247-57.
28. Bavdekar SB, Maiya PP, Rao SDS, Datta SK, Bock HL. Immunogenicity and safety of combined Diphtheriatetanus-whole cell pertussis-hepatitis B/Haemophilus influenzae type b vaccine in Indian infants. Indian Pediatr 2007; 44:505-10.
29. Gomber S, Sharma R, Ramachandran VG, Talwar V, Singh B. Immunogenicity of hepatitis B vaccine incorporated into the expanded program of immunization schedule. Indian Pediatr 2000; 37:411-3. (Pubitemid 30236157)
30. Giammanco G, Moiraghi A, Zotti C, Pignato S, Li Volti S, Giammanco A, et al. Safety and immunogenicity of a combined diphtheria-tetanus-acellular pertussis-hepatitis B vaccine administered according to two different primary vaccination schedules. Multicenter Working Group. Vaccine 1998; 16:722-6. (Pubitemid 28172538)
31. Safary A. Hepatitis B vaccination - Now and in the future. In: Hepatitis-B in India: Problems and Prevention. Eds. Sarin SK, Singhal AK. New Delhi, CBS Publishers 1996; 132-51.
32. Lansang MA. Epidemiology and control of hepatitis B infection: a perspective from the Philippines, Asia. Gut 1996; 38:43-7.
33. Lansang MA. Epidemiology and control of hepatitis B infection: a perspective from the Philippines, Asia. Gut 1996; 38:43-7.
34. Ducusin J, Dayrit E, Simbulan A, Tuazon A. A post-marketing surveillance study of a combined diphtheria, tetanus, whole-cell pertussis, and hepatitis B vaccine in the Philippines. Southeast Asian J Trop Med Public Health 2000; 31:487-92.
35. Limcangco MR, Eugene SG, Carol AL. Epidemiology of Haemophilus influenzae type b meningitis in Manila, Philippines, 1994 to 1996. Pediatric Infect Dis J 2000; 19:7-11.
36. Abucejo-Ladesma E, Simoes EA, Lupisan SP, Sombrero LT, Quiambao BP, Gozum LS, et al. Serious community-acquired paediatric infections in rural Asia (Bohol Island, Philippines): bacterial meningitis in children less than 5 years of age. Scand J Infect Dis 2007; 39:983-9. (Pubitemid 350153869)
37. Lolekha S, Cooksley G, Chan V, Isahak I, Ismael S, John J, et al. A review of Hib epidemiology in Asia. Southeast Asian J Trop Med Public Health 2000; 31:650-7.